查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1970202

全球體外毒性測試市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global In-Vitro Toxicology Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

體外毒性測試市場預計將從 2025 年的 472.8 億美元成長到 2034 年的 1,474.5 億美元，2026 年至 2034 年的複合年成長率為 13.47%。

隨著監管機構和製藥公司積極採用替代測試方法以減少動物試驗，體外毒性測試市場正經歷加速成長。未來發展預計將利用晶片器官技術、3D細胞培養和高通量篩檢平台，提供高度預測性和生理相關性的毒性數據。人工智慧和機器學習模型將增強終點分析、模式識別和預測性毒性分析。

與基於雲端的實驗室資訊管理系統 (LIMS) 和生物資訊平台整合，簡化了資料收集、儲存和解讀流程，從而加速了藥物發現和化學品安全評估中的決策。新興的機器人操作技術、微流體技術和自動化檢測平台提高了處理能力、準確性和可重複性，同時最大限度地減少了變異性。符合監管要求的體外工作流程推動了製藥、化妝品和化學工業對這些技術的廣泛應用。

未來的成長將受到倫理考量、嚴格的安全法規以及預測毒理學模型進步的驅動。透過結合高精度體外平台、人工智慧輔助分析和自動化技術，市場正在重新定義毒性測試，從而提升生命科學領域的安全性評估、營運效率和產品開發週期。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球體外毒性測試市場：依方法分類

  • 市場分析、洞察與預測
  • 細胞檢測（活細胞、固定細胞）
  • 生化分析
  • In Silico
  • Ek Vivo

第5章：全球體外毒性測試市場：依最終用途分類

  • 市場分析、洞察與預測
  • 製藥業
  • 化妝品和家居用品
  • 學術機構和研究機構
  • 診斷
  • 化工
  • 食品工業

第6章 全球體外毒性測試市場：依技術分類

  • 市場分析、洞察與預測
  • 細胞培養技術
  • 高通量技術
  • 分子影像
  • 組學技術

第7章 全球體外毒性測試市場：依應用分類

  • 市場分析、洞察與預測
  • 系統毒理學
  • 經皮毒性
  • 內分泌干擾
  • 眼毒性
  • 其他用途

第8章 全球體外毒性測試市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Merck KGaA
    • Charles River
    • Bio-Rad Laboratories Inc
    • Abbott
    • Thermo Fisher Scientific Inc
    • Catalent Inc
    • GE Healthcare
    • Quest Diagnostics Incorporated
    • Eurofins Scientific
    • Laboratory Corporation Of America Holdings
    • Evotec
    • Creative Bioarray
    • Gentronix
    • BioIVT
    • SGS SA
    • Agilent Technologies
簡介目錄
Product Code: VMR11213719

The In-Vitro Toxicology Testing Market size is expected to reach USD 147.45 Billion in 2034 from USD 47.28 Billion (2025) growing at a CAGR of 13.47% during 2026-2034.

The in-vitro toxicology testing market is poised for accelerated growth as regulatory agencies and pharmaceutical companies increasingly adopt alternative testing methods to reduce animal testing. Future advancements will leverage organ-on-chip technologies, 3D cell cultures, and high-throughput screening platforms to deliver predictive, physiologically relevant toxicity data. AI and machine learning models will enhance endpoint analysis, pattern recognition, and predictive toxicity profiling.

Integration with cloud-based laboratory information management systems (LIMS) and bioinformatics platforms will streamline data collection, storage, and interpretation, enabling faster decision-making in drug discovery and chemical safety assessments. Emerging robotic handling, microfluidics, and automated assay platforms will increase throughput, precision, and reproducibility while minimizing variability. Regulatory-compliant in-vitro workflows will expand adoption across pharmaceuticals, cosmetics, and chemical industries.

Future growth will be driven by ethical considerations, stringent safety regulations, and advancements in predictive toxicology models. By combining high-fidelity in-vitro platforms, AI-assisted analytics, and automation, the market will redefine toxicity testing, improving safety assessment, operational efficiency, and product development timelines across life sciences sectors.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Method

  • Cellular Assay (Live Cells, Fixed Cells)
  • Biochemical Assay
  • In-Silico
  • Ex-vivo

By End-use

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Academic Institutes and Research Laboratories
  • Diagnostics
  • Chemical Industry
  • Food Industry

By Technology

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

By Application

  • Systemic Toxicology
  • Dermal Toxicity
  • Endocrine Disruption
  • Ocular Toxicity
  • Other Applications

COMPANIES PROFILED

  • Merck KGaA, Charles River, BioRad Laboratories Inc, Abbott, Thermo Fisher Scientific Inc, Catalent Inc, GE Healthcare, Quest Diagnostics Incorporated, Eurofins Scientific, Laboratory Corporation of America Holdings, Evotec, Creative Bioarray, Gentronix, BioIVT, SGS SA, Agilent Technologies
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Method
  • 4.2. Cellular Assay (Live Cells, Fixed Cells) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Biochemical Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. In-Silico Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Ex-vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY END-USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-use
  • 5.2. Pharmaceutical Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cosmetics & Household Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Academic Institutes and Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Chemical Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Food Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Technology
  • 6.2. Cell Culture Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. High Throughput Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Molecular Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. OMICS Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Systemic Toxicology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Dermal Toxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Endocrine Disruption Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Ocular Toxicity Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Method
    • 8.2.2 By End-use
    • 8.2.3 By Technology
    • 8.2.4 By Application
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Method
    • 8.3.2 By End-use
    • 8.3.3 By Technology
    • 8.3.4 By Application
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Method
    • 8.4.2 By End-use
    • 8.4.3 By Technology
    • 8.4.4 By Application
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Method
    • 8.5.2 By End-use
    • 8.5.3 By Technology
    • 8.5.4 By Application
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Method
    • 8.6.2 By End-use
    • 8.6.3 By Technology
    • 8.6.4 By Application
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL IN-VITRO TOXICOLOGY TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Merck KGaA
    • 10.2.2 Charles River
    • 10.2.3 Bio-Rad Laboratories Inc
    • 10.2.4 Abbott
    • 10.2.5 Thermo Fisher Scientific Inc
    • 10.2.6 Catalent Inc
    • 10.2.7 GE Healthcare
    • 10.2.8 Quest Diagnostics Incorporated
    • 10.2.9 Eurofins Scientific
    • 10.2.10 Laboratory Corporation Of America Holdings
    • 10.2.11 Evotec
    • 10.2.12 Creative Bioarray
    • 10.2.13 Gentronix
    • 10.2.14 BioIVT
    • 10.2.15 SGS SA
    • 10.2.16 Agilent Technologies